Emerging Weight Loss Drugs: Retatrutide and Cagrisema by 2026 | Retatrutide News

Retatrutide and Cagrisema are new weight loss drugs expected by 2026, part of the GLP-1 agonist class. Eli Lilly is advancing these drugs in its metabol...
Weight Loss · October 19, 2026